The MassDevice Weekly Checkup: June 15, 2010
Our Weekly Checkup takes the temperature of the medical device industry's three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of shares outstanding for each company and each Friday's closing share price.
The Massachusetts index for the week ended June 11 closed at 5.78, up 0.6 percent compared with the prior week. Since Jan. 1, 2009, when we began tracking these companies, the index has risen 30.6 percent.
The Minnesota index for the week ended June 11 closed at 3.59, up 0.8 percent compared with the prior week. Since Jan. 1, 2009, when we began tracking these companies, the index has risen 21.6 percent.
The California index for the week ended June 11 closed at 9.01, up 3.1 percent compared with the prior week. Since Jan. 1, 2009, when we began tracking these companies, the index has risen 112.4 percent.
We also create a composite index of the three regional indices and compare it with four other indices (the S&P 500, the Dow Jones Industrial Average, the Dow's IHI medical devices index and the NASDAQ exchange):
The Weekly Checkup also compares Monday morning's opening share prices with their value when the markets close Friday afternoon to calculate the biggest gainers and losers.
Here are the 20 firms that posted the biggest share price gains and losses during the week ended June 11:
The 10 biggest gainers:
- Labspace (Alexandria Real Estate Equities): 13.4% (open $62.77; close $71.16)
- Biomerica Inc.: 11.9% (open $0.42; close $0.47)
- Clarient Inc.: 11.3% (open $2.83; close $3.15)
- iCad Inc.: 11.2% (open $1.43; close $1.59)
- Analogic Corp.: 10.8% (open $42.26; close $46.82)
- Masimo Corp.: 10.5% (open $21.41; close $23.65)
- Charles River Laboratories International Inc.: 9.2% (open $32.96; close $35.99)
- Accuray Inc.: 9.2% (open $6.01; close $6.56)
- Vascular Solutions Inc.: 9.1% (open $11.01; close $12.01)
- Cambridge Heart Inc.: 7.1% (open $0.28; close $0.30)
And the 10 biggest losers:
- Cardiogenesis Corp.: -23.5% (open $0.37; close $0.28)
- Hypertension Diagnostics Inc.: -22.2% (open $0.18; close $0.14)
- Biopure Corp.: -21.1% (open $0.04; close $0.03)
- Trimedyne Inc.: -20.6% (open $0.34; close $0.27)
- Inverness Medical Innovations Inc.: -20.3% (open $34.75; close $27.69)
- HepaLife Technologies: -14.4% (open $0.16; close $0.14)
- Ophthalmic Imaging Systems: -12.6% (open $1.03; close $0.90)
- Patient Safety Technologies Inc.: -10.4% (open $0.77; close $0.69)
- Biolase Technology Inc.: -9.5% (open $1.58; close $1.43)
- Cytori Therapeutics Inc.: -9.2% (open $4.46; close $4.05)
Disclaimer: MassDevice.com's rankings do not reflect an opinion of companies' health, prospects or viability. They are intended to provide a snapshot of publicly traded medical device companies and in no way constitute a recommendation to buy or sell any particular security, portfolio of securities, transaction or investment strategy.